Propanc Biopharma (PPCB) vs Pulmatrix (PULM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pulmatrix is the larger company by market cap ($5.4 million vs $4.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | PPCB | PULM |
|---|---|---|
| Share price | $0.486 | $1.49 |
| Market cap | $4.78M | $5.44M |
| 1-day change | -2.55% | 0.00% |
| EPS (TTM) | $-17.62 | $-1.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $48.75 | $5.24 |
| 52-week low | $0.46 | $1.16 |
| Distance from 52-week high | -99.00% | -71.54% |
| Average volume | 1.79M | 24.75K |
| Shares outstanding | 9.83M | 3.65M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
PPCB vs PULM FAQ
Which is bigger, Propanc Biopharma or Pulmatrix?
Pulmatrix (PULM) is larger, with a market capitalization of $5.44M compared with $4.78M for Propanc Biopharma (PPCB).
Are Propanc Biopharma and Pulmatrix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.